Dr. Edward Modestino, senior lecturer, Psychology, appeared in numerous publications, including an editorial titled “Have We Placed the Cart Before the Horse by Using Alpha-2 Agonists to Treat Rejection Sensitivity Dysphoria in ADHD?” a case study, “Hemiplegic migraines exacerbated using an injectable GLP-1 agonist for weight loss, “Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequences”, and "Is there a natural, non-addictive, and non-anti-reward, safe, gene-based solution to treat Reward Deficiency Syndrome KB220 variants vs. GLP-1 analogs?” In January 2024, he opened his own lab, The Brain & Behavior Laboratory, and has two Curry faculty members working with him there–Dr. Elizabeth Carey and Dr. Robert Polewan. Dr. Modestino also obtained various licenses and certifications, including a Licensed Mental Health Counselor license, a National Certified Counselor designation, an ADHD-PT (ADHD-Practitioner) certification and designation, and became Board Certified by the National Board of Certified Counselors.
Comentários